RHBC
AZN icon

R.H. Bluestein & Co’s AstraZeneca AZN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$566K Sell
10,325
-250
-2% -$13.7K 0.04% 135
2022
Q2
$699K Buy
10,575
+250
+2% +$16.5K 0.04% 131
2022
Q1
$685K Sell
10,325
-3,000
-23% -$199K 0.03% 148
2021
Q4
$776K Sell
13,325
-2,000
-13% -$116K 0.03% 142
2021
Q3
$920K Buy
15,325
+1,936
+14% +$116K 0.04% 123
2021
Q2
$802K Buy
13,389
+64
+0.5% +$3.83K 0.03% 158
2021
Q1
$663K Sell
13,325
-6,000
-31% -$299K 0.03% 161
2020
Q4
$966K Buy
19,325
+5,000
+35% +$250K 0.04% 103
2020
Q3
$785K Buy
14,325
+1,000
+8% +$54.8K 0.04% 111
2020
Q2
$705K Sell
13,325
-100
-0.7% -$5.29K 0.04% 116
2020
Q1
$600K Sell
13,425
-1,900
-12% -$84.9K 0.05% 105
2019
Q4
$764K Hold
15,325
0.04% 112
2019
Q3
$683K Hold
15,325
0.04% 110
2019
Q2
$633K Hold
15,325
0.03% 118
2019
Q1
$620K Hold
15,325
0.03% 103
2018
Q4
$582K Hold
15,325
0.05% 91
2018
Q3
$606K Sell
15,325
-200
-1% -$7.91K 0.03% 138
2018
Q2
$545K Buy
15,525
+200
+1% +$7.02K 0.03% 144
2018
Q1
$536K Sell
15,325
-1,075
-7% -$37.6K 0.03% 146
2017
Q4
$569K Buy
16,400
+1,300
+9% +$45.1K 0.03% 135
2017
Q3
$512K Sell
15,100
-44,250
-75% -$1.5M 0.03% 154
2017
Q2
$2.02M Buy
59,350
+18,100
+44% +$617K 0.12% 54
2017
Q1
$1.29M Sell
41,250
-72,300
-64% -$2.25M 0.08% 63
2016
Q4
$3.1M Sell
113,550
-224,150
-66% -$6.12M 0.2% 45
2016
Q3
$11.1M Buy
337,700
+309,700
+1,106% +$10.2M 0.73% 37
2016
Q2
$845K Sell
28,000
-5,000
-15% -$151K 0.06% 66
2016
Q1
$929K Buy
33,000
+3,000
+10% +$84.5K 0.07% 77
2015
Q4
$1.02M Hold
30,000
0.06% 77
2015
Q3
$955K Buy
30,000
+950
+3% +$30.2K 0.07% 82
2015
Q2
$1.85M Sell
29,050
-34,995
-55% -$2.23M 0.11% 60
2015
Q1
$4.38M Sell
64,045
-45,150
-41% -$3.09M 0.26% 52
2014
Q4
$7.69M Buy
109,195
+99,195
+992% +$6.98M 0.48% 52
2014
Q3
$714K Hold
10,000
0.04% 140
2014
Q2
$743K Sell
10,000
-8,000
-44% -$594K 0.04% 146
2014
Q1
$1.17M Sell
18,000
-2,000
-10% -$130K 0.08% 101
2013
Q4
$1.19M Sell
20,000
-2,000
-9% -$119K 0.07% 97
2013
Q3
$1.14M Hold
22,000
0.08% 96
2013
Q2
$1.04M Buy
+22,000
New +$1.04M 0.09% 98